{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:52:08Z","timestamp":1768679528085,"version":"3.49.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100008137","name":"Saint-Louis University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008137","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cryptococcal antigen (CrAg) is a capsule polysaccharide antigen that can be detected in the fluids of patients with cryptococcal infections. Cryptococcal Antigen Latex Agglutination System (CALAS), enzyme-linked immunosorbent assays (EIA), and lateral flow assay (LFA) are the main methods available. Two main commercial LFA kits are available: CryptoPS (Biosynex, Illkirch Graffenstaden, France) and CrAg LFA (IMMY, Inc. USA). In our lab, we prospectively used CryptoPS as a screening tool in serum for confirmed positive results with CALAS. We investigated the rigor of the CryptoPS test in serum in a multicentric evaluation over 3 years. To improve the specificity of CryptoPS in serum, we additionally implemented and evaluated a pretreatment protocol before CryptoPS testing. A total of 43 serum samples collected from 43 patients were investigated. We found that the CryptoPS assay is hampered by a high rate of false-positive results in serum with a high rate of CryptoPS-positive but CrAg LFA-negative and CALAS-negative sera in patients with no proof of Cryptococcus infection (n\u00a0=\u00a029). Using a simple pretreatment procedure (5\u00a0min incubation at 100\u00b0C and centrifugation) we were able to reverse false-positive results, suggesting that there could be interferent material present in the serum. Pretreatment also impacted the CryptoPS results (negative result) in two patients with the cryptococcal disease, one with isolated antigenemia and one with cryptococcal meningitis. Comparing the titers obtained with CALAS and CrAg LFA, we noticed that the titer obtained with CrAg LFA was almost 10-fold higher than those with CALAS. This study showed that Biosynex CryptoPS in serum could give false-positive results even in the absence of cryptococcal disease. These could be reduced by applying an easy pretreatment procedure to the serum before testing, with little but existing impact on the sensitivity.<\/jats:p>","DOI":"10.1093\/mmy\/myac078","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T12:21:01Z","timestamp":1663762861000},"source":"Crossref","is-referenced-by-count":8,"title":["Investigation of CryptoPS LFA-positive sera in patients at risk of cryptococcosis"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7752-365X","authenticated-orcid":false,"given":"Nesrine","family":"Aissaoui","sequence":"first","affiliation":[{"name":"Laboratoire de parasitologie-mycologie , AP-HP, H\u00f4pital Saint-Louis, F- 75010 Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmine","family":"Benhadid-Brahmi","sequence":"additional","affiliation":[{"name":"Laboratoire de parasitologie-mycologie , AP-HP, H\u00f4pital Saint-Louis, F- 75010 Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aude","family":"Sturny-Lecl\u00e8re","sequence":"additional","affiliation":[{"name":"Institut Pasteur , Universit\u00e9 Paris Cit\u00e9, CNRS UMR2000, Unit\u00e9 de Mycologie Mol\u00e9culaire, Centre National de R\u00e9f\u00e9rence Mycoses Invasives et Antifongiques, F- 75015 Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Hamane","sequence":"additional","affiliation":[{"name":"Laboratoire de parasitologie-mycologie , AP-HP, H\u00f4pital Saint-Louis, F- 75010 Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliane","family":"Payet","sequence":"additional","affiliation":[{"name":"Laboratoire de parasitologie-mycologie , AP-HP, H\u00f4pital Saint-Louis, F- 75010 Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Bonnal","sequence":"additional","affiliation":[{"name":"Laboratoire de parasitologie-mycologie , AP-HP, H\u00f4pital Bichat Claude-Bernard, F- 75018 Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Lise","family":"Munier","sequence":"additional","affiliation":[{"name":"Service de maladies infectieuses et tropicales, Groupe Hospitalier Lariboisi\u00e8re , Saint-Louis, Fernand Widal, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blandine","family":"Denis","sequence":"additional","affiliation":[{"name":"Service de maladies infectieuses et tropicales, Groupe Hospitalier Lariboisi\u00e8re , Saint-Louis, Fernand Widal, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9726-3082","authenticated-orcid":false,"given":"Alexandre","family":"Alanio","sequence":"additional","affiliation":[{"name":"Laboratoire de parasitologie-mycologie , AP-HP, H\u00f4pital Saint-Louis, F- 75010 Paris , France"},{"name":"Institut Pasteur , Universit\u00e9 Paris Cit\u00e9, CNRS UMR2000, Unit\u00e9 de Mycologie Mol\u00e9culaire, Centre National de R\u00e9f\u00e9rence Mycoses Invasives et Antifongiques, F- 75015 Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"2022100321284855800_bib1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/CMR.8.4.515","article-title":"Cryptococcosis in the era of AIDS\u2014100 years after the discovery of Cryptococcusneoformans","volume":"8","author":"Mitchell","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"2022100321284855800_bib2","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis ao\u00fbt"},{"key":"2022100321284855800_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"Park","year":"2009","journal-title":"Aids"},{"key":"2022100321284855800_bib4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa2111904","article-title":"Single-Dose liposomal amphotericin B treatment for cryptococcal meningitis","volume":"386","author":"Jarvis","year":"2022","journal-title":"N Engl J Med"},{"key":"2022100321284855800_bib5","doi-asserted-by":"crossref","first-page":"e13543","DOI":"10.1111\/ctr.13543","article-title":"AST infectious diseases community of practice. Cryptococcosis in solid organ transplantation-Guidelines from the american society of transplantation infectious diseases community of practice","volume":"33","author":"Baddley","year":"2019","journal-title":"Clin Transplant Sept"},{"key":"2022100321284855800_bib6","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","article-title":"Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial","volume":"385","author":"Mfinanga","year":"2015","journal-title":"Lancet"},{"key":"2022100321284855800_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3389\/fmicb.2018.00409","article-title":"Cryptococcal antigen screening in asymptomatic HIV-Infected antiretroviral na\u00efve patients in cameroon and evaluation of the new semi-quantitative biosynex CryptoPS test","volume":"9","author":"Temfack","year":"2018","journal-title":"Front Microbiol"},{"key":"2022100321284855800_bib8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/mmy\/myab038","article-title":"Association of semi-quantitative cryptococcal antigen results in plasma with subclinical cryptococcal meningitis and mortality among patients with advanced HIV disease","volume":"59","author":"Blasich","year":"2021 4","journal-title":"Med Mycol"},{"key":"2022100321284855800_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02046-19","article-title":"Evaluation of serum cryptococcal antigen testing using two novel semi-quantitative lateral flow assays in persons with cryptococcal antigenemia","author":"Skipper","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2022100321284855800_bib10","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1007\/s00284-021-02664-w","article-title":"Comparison of a lateral flow assay and a latex agglutination test for the diagnosis of cryptococcusneoformans infection","volume":"78","author":"Schub","year":"2021","journal-title":"Curr Microbiol"},{"key":"2022100321284855800_bib11","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/cid\/ciaa899","article-title":"Outcomes of reflex cryptococcal antigen (CrAg) screening in human immunodeficiency virus (HIV)-Positive patients with CD4 counts of 100-200 Cells\/\u03bcL in Botswana","volume":"72","author":"Tenforde","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2022100321284855800_bib12","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022100321284855800_bib13","doi-asserted-by":"crossref","first-page":"e0124044","DOI":"10.1371\/journal.pone.0124044","article-title":"Importance of operational factors in the reproducibility of Aspergillus galactomannan enzyme immune assay","volume":"10","author":"Guigue","year":"2015","journal-title":"PLoS One"},{"key":"2022100321284855800_bib14","first-page":"105","article-title":"Interferences in immunoassay","volume":"25","author":"Tate","year":"2004","journal-title":"Clin Biochem Rev"},{"key":"2022100321284855800_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical Practice Guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clinical Infectious Diseases"},{"key":"2022100321284855800_bib16","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0040021","article-title":"Determinants of disease presentation and outcome during cryptococcosis: the CryptoA\/D study","volume":"4","author":"Dromer","year":"2007","journal-title":"PLoS Med"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myac078\/45983620\/myac078.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/60\/10\/myac078\/46334967\/myac078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/60\/10\/myac078\/46334967\/myac078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T09:33:32Z","timestamp":1701077612000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myac078\/6712337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myac078","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10]]},"published":{"date-parts":[[2022,9,23]]},"article-number":"myac078"}}